Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
05/19/2017 05/22/2017 05/23/2017 05/24/2017 05/25/2017 Date
2460(c) 2428(c) 2421.35(c) 2390.45(c) 2362 Last
16 192 6 241 8 303 8 857 10 916 Volume
+2.27% -1.30% -0.27% -1.28% -1.19% Change
More quotes
Financials ( INR)
Sales 2018 32 738 M
EBIT 2018 5 332 M
Net income 2018 4 023 M
Finance 2018 4 100 M
Yield 2018 2,15%
Sales 2019 36 904 M
EBIT 2019 6 263 M
Net income 2019 4 747 M
Finance 2019 3 878 M
Yield 2019 2,26%
P/E ratio 2018 50,65
P/E ratio 2019 42,93
EV / Sales2018 6,10x
EV / Sales2019 5,41x
Capitalization 203 668 M
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
05/19 GLAXOSMITHKLINE PHARMACEUTICALS : records 11% Sales growth for Q4, FY 2016-17
05/16GLAXOSMITHKLINE PHARMACEUTICALS LIMI : annual earnings release
05/15 GLAXOSMITHKLINE CONSUMER HEALTHCARE : GSK faces fury from investors over pounds ..
05/13 VECTURA : Glaxo scores again as FDA strikes down would-be Advair copycats Hikma,..
04/28 GLAXOSMITHKLINE : Blockbuster drugs will lead sales bonanza at pounds sterling 8..
04/26 GLAXOSMITHKLINE PHARMACEUTICALS : Glaxo meets 1Q profit forecasts
04/26 GLAXOSMITHKLINE : Glaxo Maintains Guidance As Weak Pound Boosts First Quarter
04/26 TOP NEWS : Glaxo Holds Guidance Following "Positive Start" To 2017
04/21 AKD Securities Limited Equity Research - Trigger Shark
04/18 GLAXOSMITHKLINE : Glaxo Submits New Drug Application For Shingles Vaccine In Jap..
More news
Sector news : Pharmaceuticals - NEC
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
05/23DJALEXION PHARMACEUTICALS : Shakeup Continues as Four Executives Exit -- 2nd Updat..
More sector news : Pharmaceuticals - NEC
Latest Tweets
04/23Nigerian researchers win GSK’s Open Lab Research Grants: GlaxoSmithKline Phar.. 
2016#Indian #stocks: #Market: Glaxosmithkline Pharmaceuticals : Apr 2016 growth p.. 
2015#Indian #stocks: #Merger #Acquisition: Glaxosmithkline Pharmaceuticals : spar.. 
2015#Indian #stocks: #Market: Glaxosmithkline Pharmaceuticals : Sep 2015 growth p.. 
2015#IndiaBombay #stocks: #Merger #Acquisition: Glaxosmithkline Pharmaceuticals :.. 
More tweets
Qtime:5
Advertisement
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE P...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 2 664  INR
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Deepak Shantilal Parekh Non-Executive Chairman
Andrew Aristidou Chief Financial Officer & Executive Director
Raju Krishnaswamy Executive Director & Technical Director
Vrishali Desai Vice President-Medical & Clinical Research
D. Sundaram Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PHARMA..-11.31%3 179
JOHNSON & JOHNSON10.68%342 817
ROCHE HOLDING LTD.15.18%237 610
NOVARTIS AG6.68%213 719
PFIZER INC.-1.32%191 279
MERCK & CO., INC.10.29%175 160
More Results